Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

LORELEI trial of letrozole and taselisib for ER positive breast cancer

Dr Cristina Saura - Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain
LORELEI trial of letrozole and taselisib for ER positive breast cancer ( Dr Cristina Saura - Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain )
11 Sep 2017

Nivolumab and ipilimumab for metastatic kidney cancer

Dr Bernard Escudier - Institut Gustave Roussy, Villejuif, France
Nivolumab and ipilimumab for metastatic kidney cancer ( Dr Bernard Escudier - Institut Gustave Roussy, Villejuif, France )
11 Sep 2017

Biological insight in new drug combinations

Dr Elena Garralda - Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain
Biological insight in new drug combinations ( Dr Elena Garralda - Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain )
11 Sep 2017

Checkmate 238: Adjuvant checkpoint therapy after melanoma resection

Dr Jeffrey Weber - Perlmutter Cancer Center, New York, USA
Checkmate 238: Adjuvant checkpoint therapy after melanoma resection ( Dr Jeffrey Weber - Perlmutter Cancer Center, New York, USA )
11 Sep 2017

The role of tumour marker testing in early diagnosis

Dr Craig Barrington - South West Wales Cancer Centre, UK
The role of tumour marker testing in early diagnosis ( Dr Craig Barrington - South West Wales Cancer Centre, UK )
10 Sep 2017

The METRIC trial of trametinib, five years on

Prof Dirk Schadendorf - Essen University Hospital, Essen, Germany
The METRIC trial of trametinib, five years on ( Prof Dirk Schadendorf - Essen University Hospital, Essen, Germany )
10 Sep 2017

Patient perceptions of chemotherapy side effects differ over time and treatment

Dr Beyhan Ataseven - Kliniken Essen-Mitte, Essen, Germany
Patient perceptions of chemotherapy side effects differ over time and treatment ( Dr Beyhan Ataseven - Kliniken Essen-Mitte, Essen, Germany )
10 Sep 2017

Treatment choices in thyroid cancer

Prof Makoto Tahara - National Cancer Center Hospital East, Kashiwanoha, Japan
Treatment choices in thyroid cancer ( Prof Makoto Tahara - National Cancer Center Hospital East, Kashiwanoha, Japan )
10 Sep 2017

Clinical advances in treating colorectal cancer

Prof Michael Geißler - Klinikum Esslingen, Esslingen am Neckar, Germany
Clinical advances in treating colorectal cancer ( Prof Michael Geißler - Klinikum Esslingen, Esslingen am Neckar, Germany )
10 Sep 2017

Impact of licensing and reimbursement discrepancies on cancer care in Europe and Canada

Jan McKendrick - PRMA Consulting Ltd, Fleet, UK
Impact of licensing and reimbursement discrepancies on cancer care in Europe and Canada ( Jan McKendrick - PRMA Consulting Ltd, Fleet, UK )
10 Sep 2017

New strategies in melanoma care

Dr Alexander van Akkooi - Netherlands Cancer Institute, Amsterdam, Netherlands
New strategies in melanoma care ( Dr Alexander van Akkooi - Netherlands Cancer Institute, Amsterdam, Netherlands )
10 Sep 2017

RANGE trial of ramucirumab for urothelial cancer

Prof Daniel Petrylak - Yale Cancer Center, New Haven, Connecticut, USA
RANGE trial of ramucirumab for urothelial cancer ( Prof Daniel Petrylak - Yale Cancer Center, New Haven, Connecticut, USA )
10 Sep 2017